Single-enantiomer drugs represent an increasingly large share of new chemical entities, leading to approaches in asymmetric synthesis.
Ian C. Lennon
Advertisement
Ian C. Lennon, PhD, is a scientist and technology leader at Chirotech Technology Ltd.
Articles by Ian C. Lennon
Advertisement
Latest Updated Articles
Manufacture of Asymmetric Hydrogenation CatalystsPublished: October 4th 2007 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops
2
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
3
FDA Deploys Agentic AI Capabilities for Agency Staff
4
Live Cell High-Content Imaging is Driving Drug Discovery
5
